Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.
This prospective study followed 128 patients with hematologic malignancies receiving CAR T-cell therapy targeting CD19,...
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.
- Post category:Hematologic Cancers
- Reading time:1 min read
Phase 3 EMN24 IsKia trial: transplant-eligible newly diagnosed multiple myeloma (≤70 years) Design - 302 patients r...
Gamut of Patients Referred to Cardiology for Question of Clonal Hematopoiesis.
- Post category:Hematologic Cancers
- Reading time:2 mins read
This publication reviews how clonal hematopoiesis (CH) presents in patients seen by cardiologists and how it should info...
Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide study.
- Post category:Hematologic Cancers
- Reading time:1 min read
This nationwide retrospective study analyzed 7175 patients with MDS or MDS/MPN who underwent first allogeneic HSCT betwe...
Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel.
- Post category:Hematologic Cancers
- Reading time:2 mins read
This publication is a special report presenting consensus guidelines for the diagnosis and management of acute myeloid l...
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).
- Post category:Hematologic Cancers
- Reading time:2 mins read
This study evaluated why only some patients with t(11;14)(CCND1;IGH) multiple myeloma benefit durably from venetoclax....